A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

Clinical trial NCT05334823 · UNKNOWN

Trial details

NCT number: NCT05334823
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Relapsed Pediatric ALL Refractory Acute Lymphoblastic Leukemia

Start date: 2022-01-26
Primary completion: 2024-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.